Seek truth from facts, competitive symbiosis
The 91st China Pharmaceutical Fair kicked off with great fanfare, and Zhengqing Group’s products have attracted considerable attention.
Category:
Release time:
2025-11-21
From November 19 to 21, 2025, the highly anticipated 91st National Pharmaceutical Fair will be grandly held at the Nanjing International Expo Center. Zhengqing Group will make a strong appearance at Booth 8E20-5 in Hall 8 (within the Hunan Pharmaceutical Exhibition Delegation), showcasing its core products. With robust R&D capabilities, an extensive product portfolio, and a sincere attitude toward cooperation, the group has become one of the highlights of the fair.
At this exhibition, Zhengqing Group has carefully selected its flagship products for display, covering four major categories: achievements from academician-led projects, exclusive essential medicines, nationally designated essential medicines, and specialty products. This comprehensive showcase highlights the company’s deep-rooted R&D expertise and strong product capabilities in the field of traditional Chinese medicine. Among them, the Zhengqing Fengtongning series—a star product of the group—has drawn particular attention. This product fills a domestic gap in sustained-release formulations of traditional Chinese medicine and has consistently ranked first in Hunan Province’s list of top-scoring traditional Chinese medicines in terms of scientific and technological competitiveness thanks to its outstanding therapeutic efficacy. Not only is it highly acclaimed in the domestic market, but it is also gradually expanding into international markets, serving as a model for innovative development in traditional Chinese medicine. The Zhengqing Ganoderma series and Qingre Jiedu Granules—classic products of the group—were also on display simultaneously. The latter, due to its proven efficacy, was included in Hunan Province’s recommended list of proprietary Chinese medicines for COVID-19 prevention and treatment, attracting numerous agents and distributors to stop and discuss business opportunities.
During the conference, the successful 50-person business forum for Zhengqing Fengtongning was held. At the forum, the academic manager presented the latest progress in research and promotion of the Zhengqing Fengtongning product, as well as the implementation status of the academician-led grassroots projects. Partner Mr. Qiu from Guangdong Daxiang shared his experience over the past few years in promoting the sequential triple therapy for rheumatism and pain, which has led to year-on-year growth in sales of the Zhengqing Fengtongning product line and Qingre Jiedu Granules. Wang Xianping, General Manager of the Marketing Center, summarized the work done in 2025 and outlined the marketing plans for 2026. The atmosphere at the event was enthusiastic, with numerous new and existing customers expressing high recognition of Zhengqing and its products, and indicating their anticipation for even deeper cooperation in the future.
Although this year’s expo has come to a close, the curtain has just been raised on a new chapter of collaboration. In the future, Zhengqing Group will continue to deepen its engagement in the field of traditional Chinese medicine, consistently strengthen scientific research and innovation, optimize product portfolios, and deepen win-win cooperation with industry partners. We will steadily advance on the path of modernizing and internationalizing TCM, contributing even more to the building of a Healthy China!
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Virtual Showroom：
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地